Professor Mary Keogan:

It is extremely important that any testing is rolled out in the context of quality management systems. There is checking of each batch that comes in, checking of batches of antigen tests against variants to ensure their performance is not compromised, membership of external quality assurance schemes and so forth. We have very detailed near-patient testing guidelines which should be applied in any setting where the tests are considered for use.